Antibiotic susceptibilities of recent isolates of Mycoplasma bovis in Belgium.
about
Mycoplasma bovis: Mechanisms of Resistance and Trends in Antimicrobial SusceptibilityClinical-pathological findings of otitis media and media-interna in calves and (clinical) evaluation of a standardized therapeutic protocol.Integrated pharmacokinetic-Pharmacodynamic (PK/PD) model to evaluate the in vivo antimicrobial activity of Marbofloxacin against Pasteurella multocida in piglets.Antibiotic susceptibility profiles of Mycoplasma bovis strains isolated from cattle in Hungary, Central EuropeOverall decrease in the susceptibility of Mycoplasma bovis to antimicrobials over the past 30 years in France.16S rRNA gene mutations associated with decreased susceptibility to tetracycline in Mycoplasma bovisIntegration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.Pharmacokinetics/pharmacodynamics of marbofloxacin in a Pasteurella multocida serious murine lung infection model.Alterations in the Quinolone Resistance-Determining Regions and Fluoroquinolone Resistance in Clinical Isolates and Laboratory-Derived Mutants of Mycoplasma bovis: Not All Genotypes May Be Equal.Mycoplasma bovis pneumonia in cattle.Antimicrobial resistance in zoonotic bacteria: lessons learned from host-specific pathogens.In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates.Pharmacokinetic/pharmacodynamic relationship of marbofloxacin against Pasteurella multocida in a tissue-cage model in yellow cattle.Clinical signs, computed tomographic imaging, and management of chronic otitis media/interna in dairy calves.Efficacy of metaphylactic florfenicol therapy during natural outbreaks of bovine respiratory disease.Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in calves.In vitro antimicrobial inhibition profiles of Mycoplasma bovis isolates recovered from various regions of the United States from 2002 to 2003.
P2860
Q26747448-D1ECB6CE-9F93-46AD-9F06-A3305FBF2E54Q30396718-20DACEED-845F-44B1-86DD-D80CD09EB113Q33802390-DE3D4192-29A6-4D20-B3F9-1110B3965786Q34410139-059DB595-0C50-44F4-B267-D8E98CAB1DCBQ35087670-6E54E06B-A507-4510-AB9B-4CAA2B9A35B5Q35105951-559AD194-CFE5-4EE0-9233-5DA38918DB4CQ35127800-E7A37717-B29B-45E0-A2CB-22A829689229Q35859460-25E18C4A-DC7C-42A3-B249-ACDCA0C8D3DBQ36575147-9A23FD38-4BE4-442A-91EC-6B56805F12C9Q37064551-33202484-D0E5-45C6-93F5-F803C7F58A49Q37356539-D24C25D6-9691-40E4-913C-8DFEC3639063Q40290234-F2481D1B-B30C-481A-B55B-ECF80F222683Q43509434-5723A35A-66BA-4C7D-A4C7-F4422A835E40Q45215484-B05BC5EB-5FFB-46DB-B56E-DE9A1614D3B4Q46254042-A3C4239A-3EA5-4FA4-A134-DEEE802ABB68Q46518946-83DEB4C7-8D7F-4601-B598-98916EFA77F4Q46823853-CFF7EC66-079E-4655-B9C6-F04C249FB550
P2860
Antibiotic susceptibilities of recent isolates of Mycoplasma bovis in Belgium.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Antibiotic susceptibilities of recent isolates of Mycoplasma bovis in Belgium.
@en
Antibiotic susceptibilities of recent isolates of Mycoplasma bovis in Belgium.
@nl
type
label
Antibiotic susceptibilities of recent isolates of Mycoplasma bovis in Belgium.
@en
Antibiotic susceptibilities of recent isolates of Mycoplasma bovis in Belgium.
@nl
prefLabel
Antibiotic susceptibilities of recent isolates of Mycoplasma bovis in Belgium.
@en
Antibiotic susceptibilities of recent isolates of Mycoplasma bovis in Belgium.
@nl
P2093
P356
P1433
P1476
Antibiotic susceptibilities of recent isolates of Mycoplasma bovis in Belgium
@en
P2093
P304
P356
10.1136/VR.153.14.428
P407
P577
2003-10-01T00:00:00Z